Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Operating Leases (2019 - 2025)

Collegium Pharmaceutical has reported Operating Leases over the past 7 years, most recently at $4.1 million for Q4 2025.

  • Quarterly results put Operating Leases at $4.1 million for Q4 2025, down 25.4% from a year ago — trailing twelve months through Dec 2025 was $4.1 million (down 25.4% YoY), and the annual figure for FY2025 was $4.1 million, down 25.4%.
  • Operating Leases for Q4 2025 was $4.1 million at Collegium Pharmaceutical, down from $4.5 million in the prior quarter.
  • Over the last five years, Operating Leases for COLL hit a ceiling of $8.6 million in Q1 2021 and a floor of $4.1 million in Q4 2025.
  • Median Operating Leases over the past 5 years was $6.5 million (2023), compared with a mean of $6.5 million.
  • Biggest five-year swings in Operating Leases: fell 7.36% in 2024 and later decreased 25.4% in 2025.
  • Collegium Pharmaceutical's Operating Leases stood at $8.0 million in 2021, then fell by 10.55% to $7.1 million in 2022, then dropped by 13.89% to $6.1 million in 2023, then dropped by 9.55% to $5.5 million in 2024, then decreased by 25.4% to $4.1 million in 2025.
  • The last three reported values for Operating Leases were $4.1 million (Q4 2025), $4.5 million (Q3 2025), and $4.9 million (Q2 2025) per Business Quant data.